The Scientific World Journal

The Scientific World Journal / 2021 / Article

Research Article | Open Access

Volume 2021 |Article ID 6642626 |

Khyber Shinwari, Liu Guojun, Svetlana S. Deryabina, Mikhail A. Bolkov, Irina A. Tuzankina, Valery A. Chereshnev, "Predicting the Most Deleterious Missense Nonsynonymous Single-Nucleotide Polymorphisms of Hennekam Syndrome-Causing CCBE1 Gene, In Silico Analysis", The Scientific World Journal, vol. 2021, Article ID 6642626, 19 pages, 2021.

Predicting the Most Deleterious Missense Nonsynonymous Single-Nucleotide Polymorphisms of Hennekam Syndrome-Causing CCBE1 Gene, In Silico Analysis

Academic Editor: Antonio J. Piantino Ferreira
Received22 Oct 2020
Accepted27 May 2021
Published14 Jun 2021


Hennekam lymphangiectasia-lymphedema syndrome has been linked to single-nucleotide polymorphisms in the CCBE1 (collagen and calcium-binding EGF domains 1) gene. Several bioinformatics methods were used to find the most dangerous nsSNPs that could affect CCBE1 structure and function. Using state-of-the-art in silico tools, this study examined the most pathogenic nonsynonymous single-nucleotide polymorphisms (nsSNPs) that disrupt the CCBE1 protein and extracellular matrix remodeling and migration. Our results indicate that seven nsSNPs, rs115982879, rs149792489, rs374941368, rs121908254, rs149531418, rs121908251, and rs372499913, are deleterious in the CCBE1 gene, four (G330E, C102S, C174R, and G107D) of which are the highly deleterious, two of them (G330E and G107D) have never been seen reported in the context of Hennekam syndrome. Twelve missense SNPs, rs199902030, rs267605221, rs37517418, rs80008675, rs116596858, rs116675104, rs121908252, rs147974432, rs147681552, rs192224843, rs139059968, and rs148498685, are found to revert into stop codons. Structural homology-based methods and sequence homology-based tools revealed that 8.8% of the nsSNPs are pathogenic. SIFT, PolyPhen2, M-CAP, CADD, FATHMM-MKL, DANN, PANTHER, Mutation Taster, LRT, and SNAP2 had a significant score for identifying deleterious nsSNPs. The importance of rs374941368 and rs200149541 in the prediction of post-translation changes was highlighted because it impacts a possible phosphorylation site. Gene-gene interactions revealed CCBE1’s association with other genes, showing its role in a number of pathways and coexpressions. The top 16 deleterious nsSNPs found in this research should be investigated further in the future while researching diseases caused CCBE1 gene specifically HS. The FT web server predicted amino acid residues involved in the ligand-binding site of the CCBE1 protein, and two of the substitutions (R167W and T153N) were found to be involved. These highly deleterious nsSNPs can be used as marker pathogenic variants in the mutational diagnosis of the HS syndrome, and this research also offers potential insights that will aid in the development of precision medicines. CCBE1 proteins from Hennekam syndrome patients should be tested in animal models for this purpose.

1. Introduction

Lymphangiogenesis is a process that helps the lymphatic system in its development. This includes migrations, proliferation, and budding of endothelial lymphatic progenitor cell lines [13]. The interstitial fluids, which are normally stored in the cardiovascular system, frequently flow away due to irregular Lymphangiogenesis, and this drainage can cause chylothorax, pleural effusion, angiectasias, lymphedema, and chylous ascites of lymph vessels in various organs, including the intestines [4]. Dysplasias’s symptoms of lymph vessels are usually reserved for the limbs [1]. Hennekam syndrome is a genetically heterogeneous condition. Hennekam lymphangiectasia is a condition marked by disorders of the lymphatic system, which affects a variety of organs and links the gastrointestinal tract and the pericardium. Lymphedema demonstrates abnormal facial dysmorphism and cognitive dysfunction [5]. Approximately, up to now 45 people have been diagnosed with HS syndrome [6]. Almost 25% of patient’s diseases are influenced by biallelic mutations in CCBE1 (Hennekam lymphangiectasia-lymphedema syndrome 1 (HKLLS1; MIM: 235510)) and FAT4 (Hennekam lymphangiectasia-lymphedema syndrome 2 (HKLLS2; MIM: 616006)) while CCBE 1 gene mutation [7]. In the examination of two siblings with missense, the type was found the biallelic mutation in the ADAMTS3 gene [8]. In humans and model organisms, the signaling protein collagen- and calcium-binding domain 1 (CCBE1) is required for lymphangiogenesis. As per forward genetic screening in zebrafish for a causative coding mutation in CCBE1, there is a mutant known as full of fluid (fof) that misses the thoracic duct’s truncal lymphatic vessels but retains normal blood vasculature [9]. Missense mutation in the CCBE1 gene in the protein functional domain or upstream cysteine-rich domain of EGF was identified as the causative agent of HKLLS1 [6]. The CCBE1 gene plays a significant role in the growth of the lymphatic system in a model organism [9, 10]. However, the connection between FAT4 and lymphatic development is still not clear. Over time, our understanding of the phenotype associated with the CCBE1 mutation evolves. In the original account, the key inconsistency in the degree of cognitive damage (expansion from normal to moderate damage) is displayed by Hennekam syndrome subjects [11]. Specimens with clinically diagnosed Hennekam syndrome with or without mutations in CCBE1 were compared in the most recent study [6]. The CCBE1 gene interacts with connective tissue in the extracellular matrix and is then secreted [1012]. Zebrafish often lacks lymphatic vessels and thoracic ducts, as well as the ability to develop edema [9, 11]. A mutation in the CCBE1 gene confirmed this. The same case of developing edema was shown in mice models [10]. On this basis, a mutation in this gene, which is thought to be the key gene between organisms, was linked to vascular lymphatic system dysfunction, leading to the conclusion that the human CCBE1 mutation is linked to widespread lymphatic dysplasia. Aagenaes syndrome, a rare AR condition, has also been linked to the biallelic CCBE1 mutation. This rare condition causes neonatal intrahepatic cholestasis, extreme chronic lymphedema without mental retardation, and lymphangiectasia [13]. Aagenaes syndrome was common in untreated children, and fetal hydrops was also found in HS patients [13, 14]. The proof that disease is caused by the rarity of a mutated allele is supported by the CCBE1 gene triggering the mutation in the latest evidence. Because of their segregation of phenotype in an AR inheritance model, their sporadic repetition in unrelated organisms, and the large number of associated carrying mutations, these mutated alleles may have a harmful impact [15]. Molecular biology, statistics, mathematics, computer science, and genetics all fall under the umbrella of bioinformatics [16]. Single-nucleotide polymorphism is the most common genetic variation present in the general population (SNPs). Every single nucleotide in the entire genome has been modified by SNPs. There are 200–300 bp SNPs in the human genome, but there are 5000,000 SNPs in the entire human genome. This can result in a variety of sequence changes, which can contribute to abnormal function [1719]. Aside from SNPs in the exonic region of the genome, nonsynonymous SNPs (ns SNPs) and amino acid sequence changes in gene products are often affected by genetic variation (ns SNPs). SNPs do not have a large biological impact, but they can disclose a variety of disorders, such as affecting immunological response to drugs, and in some cases, SNPs can be used as biomarkers for disease vulnerability [20]. Changes in amino acid sequence caused by SNPs are responsible for 50% of reported cases of inheritance disorders [21]. Gene expression and transcription factor binding are also affected by promoter regions and regions outside of the gene [22, 23]. Single-nucleotide polymorphisms have a critical role to play in determining an individual’s susceptibility to various diseases and drug reactions (SNPs). SNPs that cause disorders are discovered biologically through a simple procedure, so it is critical that we find them before they are used as a tool in genetics technologies [24]. Alignment methods based on matrix and data tree structure computation are used in the tools. Recent results, such as [25, 26], show that hash-based functions can speed up the entire process. The aim of this study is to use a variety of in silico approaches based on different concepts to investigate the potentially harmful effects of nsSNPs in the CCBE1 gene and protein. The study’s aim is to provide a valuable tool for quick and cost-effective screening for pathologic nsSNPs, rather than biological experiment validation.

2. Methods

2.1. SNP Retrieval

Entrez Gene on the website of the National Center for Biological Information (NCBI) was collected from the data of the human CCBE1 gene. The information of SNP (protein accession number and SNP ID) of the CCBE1 gene was gained from NCBI dbSNP ( and SwissProt databases ( There was also searched other databases as Exome Aggregation Consortium, Genome Variation Server, and F-SNP to cross-check the nonsynonymous SNP (nsSNP) data for the CCBE1 gene [27]. The databases were accessed: 3 July 2020.

2.2. GeneMANIA

To check the interaction of the CCBE1 gene and observation of its association with other genes in order to predict the effect of nsSNPs on other related genes was used, GeneMANIA ( and STRING ( (accessed on 6 July 2020 using manual search for CCBE1 in the search box) [28]. Prediction of gene-gene interaction by GeneMANIA is that interaction is based on the basis of pathways, colocalization, coexpression protein domain similarity, genetic, and protein interaction. Predictions of STRING were limited to the top 10 best interactive genes with parameters that included gene fusion, co-occurrence, coexpression, and experimental and biochemical data. Those data showed a combined score for each gene’s interaction with the target gene in range from 0 to 1, when 0 was the lowest interaction and 1 was the highest interaction. Therefore, CCBE1 was presented as our input gene and that generated the gene-gene interaction network.

2.3. Prediction Tool Used for nsSNP
2.3.1. Sequence Homology Tool (SIFT)

For every sequences of query, the SIFT takes referential SNP ID and sequence of query by using multiple closely related information to prediction of tolerated and damaging substitutions [29, 30]. It tells whether the substitution is tolerated at that position. The tool was used on 6 July 2020.

2.3.2. PolyPhen

( PolyPhen predicts by using specific empiric rules the effect of amino acids substitution on the protein’s structure and function. Protein sequence, amino acid position, database ID/accession number, and amino acid variant details are the input for the PolyPhen [31], and the score difference between variants and wild-type amino acid is calculated. The tool was used on 6 July 2020.

2.3.3. Analysis and Identification of the Most Damaging SNPs

Many algorithms for prediction of functional impact confirmed nonsynonymous single-nucleotide polymorphisms (nsSNPs). Those algorithms are SIFT [29, 30], PolyPhen2 [31], PROVEAN [32], M-CAP, LRT, META SVM, MetaLR, FATHMM-pred, FATHMM-MKL-coding-pred, Mutation Assessor, VESST3 CAAD, DANN, Mutation Taster by VarCARD [33], SNP-GO, PhD-SNP and PANTHER [34, 35], and SNAP2 [36]. These tools were used from 8 to 25 July 2020.

2.4. Prediction of Disease-Related Amino Acid Substitution and Phenotypes by MutPred

The online server MutPred ( is used as searching tool for prediction of the molecular basis of the disease which is related with amino acid substitution in a mutant protein [37]. It uses several attributes that are related to protein structure, function, and evolution. There are used three servers, PSI-BLASAT, SIFT, and Pfam profiles, along with TMHMM, MARCOIL, and DisProt algorithms. These are the prediction of some structural damages. The greater accuracy of prediction is reached by combining of the scores of all those three servers.

2.5. Prediction of Stability of the Mutated Protein due to SNPs by iStable 2.0

Amino acid substitutions are caused by missense SNPs and can change the stability of native protein which can lead to influencing of protein and in the end lead to diseases [38]. By a metaclassifier, iStable 2.0, we are predicting changes due to missense SNPs in protein stability. This metaclassifier uses machine learning and investigates the increasing or decreasing stability of the protein. It happens due to an amino acid substitution which is based on prediction of 8 structural-based (I-Mutant2.0, CUPSAT, PoPMuSiC, AUTO-MUTE2.0, SDM, DUET, mCSM, MAESTRO, and SDM2) and 3 sequential-based (I-Mutant2.0, MUpro, and iPTREESTAB) tools of stabilization’s prediction. 4-letter PDB code or protein sequence in FASTA format is used as input, but the structural predictor achieves better performances than the sequential predictor. At the web server, can be found, the iStable 2.0.

2.6. Identification of Conserved Residues and Sequence Motifs

Sequence of human-CCBE1 protein UniProt showed markable comparison up to maximum of 100 sequences, and it was blasted against the UniProtKB/SwissProt database in NCBI ( To perform, another computational analysis of the sequence was used, Clustal Omega. It showed more than 50% identity and E-value under 1, 00E-20 [39]. The amino acids identified were colored by scheme of Clustal color, and the alignment position conservation index was provided by Jalview [40].

2.7. Prediction of Amino Acid Conservation by ConSurf (

Bayesian empirical inference is used to calculate evolutionary conversation sequence of amino acid within a sequence of protein. This inference is giving us conservation scores along with schemes of color. Variable amino acid gets score 1, while the most conserved amino acid gets score 9. To ConSurf analysis was submitted the FASTA sequence of CCBE1 protein [41].

2.8. Project HOPE

Analysis of structural effects of the intended mutation is performed by the website Project HOPE. In cooperation with UniProt and DAS servers of prediction, the HOPE Project shows the mutated protein in an observable 3D structure. Project HOPE is the protein sequence used as the input source, and then the wild-type amino acid comparison of the structure is performed [42].

2.9. Secondary Structure Prediction by NetSurfP

In a fully folded protein, to identify the interaction interfaces or active sites is necessary knowledge of amino acid surface and accessibility of solvent. When the amino acid substitutions in such sites are noticed, then the affinity of binding is disturbed [43]. Binding affinity is also disturbed by catalytic activity when an enzyme is a protein. Surface and solvent accessibility, structural disorder, backbone dihedral angles, and secondary structure, for amino acid residues, can be effectively estimated by NetSurf-2.0. Protein sequences in FASTA format are utilized as input. They recruit deep neural nets that were trained on solved protein structures [43]. The availability of NetSurfP-2.0 is on the website

2.10. Predicting 3D Protein Structure

The 3D homology modelling tool that can predict 3D models of proteins is called Phyre2 (∼phyre 2/html/page.cgi?xml:id = index) [44]. There were generated 3D models of wild-type CCBE1 with its 23 mutants associated with most deleterious nsSNPs. TM-align ( was used for comparison of the wild-type CCBE1 and selected mutants. There were predicted TM-score (template modelling score), RMSD (root-mean-square deviation) and structural superposition. The range of TM-scores is provided from 0 to 1, where 1 is identified as a higher structural similarity. The greater will be the variation between mutant and wild-type structures, the higher will be the RMSD values [45, 46]. To I-TASSER for further study of 3D protein structure study (, were submitted 3 mutants with higher RMSD along with the wild-type CCBE1 [47, 48, 49]. Chimera v1.11 was used to investigate molecular characteristics and to visualize the resulting protein structure interactively [50].

2.11. PTM Site Prediction

Post‐translation modification (PTM) in protein is used to predict the function of the protein. GPS‐MSP v3.0 ( was used to predicate methylation sites in CCBE1 protein [51]. At residual positions of serine, tyrosine, and threonine at CCBE1 sequence of protein, the prediction of phosphorylation sites is made by using GPS 3.0 ( [52] and NetPhos 3.1 ( By employing NetPhos 3.1 for neural network ensembles, a threshold of 0.5 was created, which predicted more specific findings than GPS 3.0 [53]. There was a prediction that residues having a higher score than threshold should be phosphorylated. To the prediction of ubiquitylation sites in CCBE1 protein were used BDM‐PUB ( and UbPred ( UbPred had chosen a balanced cutoff [37] for lysine residues that were predicted ubiquitinated to have scored at or above the 0.62 thresholds [54]. NetOglyc4.0 ( predicted glycosylation, which is another very important post-transcriptional event [55]. The website of NetOglyc4.0 is analyzing protein sequence with amino acid substitution and also a wild-type protein sequence. Mutation is functionally significant when there is difference between the functional pattern in mutant type and wild type. There is the prediction that glycosylation sites with higher score than threshold 0.5 will be glycosylated.

2.12. Ligand-Binding Site Prediction by FTSite Server

(http://FTSite.buedu/) Server FTSite has predicted the ligand-binding site in the 3D protein structure. Prediction of this site is based on energy, and the binding site over 94% of the apoproteins is identified. To the prediction of the hotspot, ligand-binding used PDB data as input.

2.13. Statistical Analysis

Computational in silico tool predication was subjected to correlation analysis using SPSS v23 and MS excel. The various computational tool prediction significance differences were compared using Student’s t-test. A value <0.01 was considered significant.

3. Results

3.1. Exploring the Desired Gene Using dbSNPs/NCBI

CCBE1 gene SNP data were searched in the NCBI database ( It contains a total of 73845 SNPs, which were present in Homo sapiens, 407 were found in nonsynonymous regions (missense), and 156 were in synonymous as shown in Figure 1.

3.2. GeneMANIA

The CCBE1 gene provides instructions for making a protein that is found in the extracellular matrix of protein lattice and other molecules. The CCBE1 protein is involved in the formation of the lymphatic system. Specifically, the CCBE1 protein helps guide immature cells called lymphangioblast maturation (differentiation) and movement (migration) that will eventually form the lining (epithelium) of lymphatic vessels. Our findings revealed that CCBE1 is coexpressed with 17 genes (COL6A6, MXRA8, PLEKHF2, RPRM, CDH4, PLEKHG1, CAND1, MY010, LRRC4C, LRAT, ANK3, OLFM1, DCN, NEURL1B, PLEKHH2, GLTSCR2, and NDRG2) and shared domain with only 2 genes (PLEKHH2 and DCN), physical interaction with two genes (SIAH2 and TOX4), and colocalization with 2 genes (MYRA8 and DCN). Predictions resulted from STRING showed combined score for each of the genes and showed interaction of the gene with FLT4, VEGFC, ADAMTS3, GJC2, FLGF, FAM43A, SNX29, PKD2L2, and PHF5A. Gene interactions predicted by GeneMANIA (Figures 2(a) and 2(b) and Table 1) and STRING (Figure 2(c)) are given in Figure 2, respectively.

Gene symbolDescriptionCoexpressionShared domain

COL6A6Collagen type VI alpha 6YesNo
MXRA8Matrix remodeling associated 8YesNo
PLEKHF2Pleckstrin homology and FYVE domain containing 2YesNo
RPRMReprimo, TP53 dependent G2 arrest mediator candidateYesNo
CDH4Cadherin 4NoNo
PLEKHG1Pleckstrin homology and RhoGEF domain containing G1YesNo
CAND1Cullin associated and neddylation dissociated 1YesNo
MYO10Myosin XYesNo
LRRC4CLeucine rich repeat containing 4CYesNo
LRATLecithin retinol acyltransferaseYesNo
ANK3Ankyrin 3, node of RanvierYesNo
OLFM1Olfactomedin 1YesNo
NEURL1BNeuralized E3 ubiquitin protein ligase 1BYesNo
PLEKHH2Pleckstrin homology, MyTH4, and FERM domain containing H2YesYes
GLTSCR2Glioma tumor suppressor candidate region gene 2YesNo
NDRG2NDRG family member 2YesNo

3.3. Prediction of Deleterious nsSNP by SIFT and PolyPhen in CCBE1

A total of 407 nsSNPs (missense) were screened to find their effect on protein structure and function. The first step was to predict the nsSNP carried out the amino acid substitution. SIFT predicts the effect of nsSNP on protein structure and tells whether the induced amino acid is tolerable at that position or not. Out of a total of 407 nsSNPs, 23 were found to be deleterious with a tolerance index score of 0.00 on the SIFT network, as well as on prediction matching of highly pathogenic nsSNPs with a PSIC score of >0.5 on the PolyPhen server. There 11 nsSNPs contained the information of minor allele frequency (MAF). Except for T153N, G107D, P249S, S19N, C75S, C102S, G327 R, C174R, D397Y, R125W, P87W, and G330E, other MAFs of nsSNPs might be lower than 1% (Table 2).

ID of nsSNPsAA positionSIFTScorePolyPhen2ScoreMAF

rs199902030D336NDeleterious0.003Probably damaging1<0.001 (T)
rs200149541T153NDeleterious0.001Probably damaging1
rs372499913G107DDeleterious0Probably damaging1
rs267605221P249SDeleterious0.007Probably damaging1
rs374941368S19NDeleterious0.004Probably damaging0.981
rs375717418R301WDeleterious0.004Probably damaging1<0.001 (T)
rs80008675D41EDeleterious low0.016Probably damaging0.9820.017 (T)
rs116596858P181SDeleterious low0.007Probably damaging0.906<0.001 (A)
rs116675104R167WDeleterious low0.017Probably damaging0.9900.003 (A)
rs121908250C75SDeleterious low0.002Probably damaging0.981
rs121908251C102SDeleterious low0Probably damaging0.999
rs121908252G327RDeleterious0Probably damaging1
rs121908254C174RDeleterious0.001Probably damaging0.984
rs147974432T144MDeleterious low0.002Probably damaging1<0.001 (A)
rs192224843Q353RDeleterious0.011Probably damaging0.993<0.001 (C)
rs115982879R118LDeleterious low0.001Probably damaging0.910<0.001 (T)
rs139059968K355TDeleterious0.002Probably damaging0.883<0.001 (G)
rs141125426D397YDeleterious low0.002Probably damaging0.828
rs147208835R125WDeleterious low0Probably damaging0.995
rs147681552P290LDeleterious0.005Probably damaging1<0.001 (A)
rs148498685P87SDeleterious low0.002Probably damaging1
rs149531418G330EDeleterious0Probably damaging0.999
rs149792489A96GDeleterious low0.004Probably damaging1<0.001 (C)

Threshold. SIFT: <0.05; PolyPhen2: >0.8 (PSIC > 0.5) or Benign (PSIC < 0.5).
3.3.1. Confirmation of Delirious nsSNP by Different Tools in CCBE1

Fifteen in silico algorithms were used to confirm 23 deleterious/damaging nsSNPs predicated by SIFT and PolyPhen. These tools were used for confirmation analysis PROVEAN, FATHMM, LRT, M-CAP, VEST3, CAAD, MetaLR, DANN, Mutation Assessor, Mutation Taster, FATHMM-MKL, SNP-GO, PhD-SNP, PANTHER, and SNAP2. Any of the seventeen prediction tools was used independently or in combination with a tool that showed the effects of several prediction tools. Each method has a different number of deleterious SNPs. SIFT classified 36 and PolyPhen 23 nsSNPs as damaging or deleterious, but PolyPhen did not demonstrate any of the damaging 13 nsSNPs that SIFT classified as deleterious. With a cutoff of >0.5, SNP-GO revealed the fewest 4 SNPs (17.23%) in total of 23 SIFT- and PolyPhen-predicated nsSNPs in the CCBE1 gene as damaging or deleterious, and 19 as neutral. Using SNAP2 tool, 18 (78.26%) (09 effective nsSNPs : SNAP2 score 0 to 50; 09 highly effective: SNAP2 score 50 to 100) and 05 were neutral (SNAP2 score −100). The deleterious and damaging effects of 21 (91.23%) nsSNPs in which 18 nsSNPs probably damaging, 3 nsSNPs as possibly damaging, and 2 (8.6%) probably benign (time > 450my “possibly damaging,” 450my > time > 200my, “probably benign,” and time < 200my on CCBE1 protein), were predicted using the PANTHER (Figure 1 S4). Furthermore, the analysis was carried out using the PROVEAN, which predicts the impact of SNP on the biological function of a protein. A total of 11 (47.82%) nsSNPs of CCBE1 gene were predicted to be highly deleterious using PROVEAN having cutoff >−2.667 (Figure 1 S4), and 12 nsSNPs were neutral. Mutation Assessor predicates 3 nsSNPs high, 9 medium, 8 low, and 2 as neutral with a threshold of >0.65 (−5.545 to 5.975 (higher score‐>more damaging). FATHMM-MKL (<0.5), CADD (>15), and M-Cap (>0.025) with respective scores show all 23 (100%) nsSNPs as deleterious/damaging. DANN predicated 19 deleterious and 4 as tolerated with cutoff (>0.5). Mutation Taster with a threshold of (<0.5) predicated 21 (91.30%) as deleterious and 2 as polymorphic while VEST3 predicated 15 (65.21%) deleterious and 8 tolerated with a cutoff (<0.5). FATHMM with a score of (>0.453) predicated 17 (73.91%) nsSNPs deleterious and 5 as tolerated, while LRT predicated 19 (82.60%), with score >0.001, nsSNPs deleterious and 4 as neutral. PhD-SNP showed 13 (56.56%) deleterious SNPs and 10 neutral. FATHMM-MKL Furthermore, on the PolyPhen server, prediction matching of highly pathogenic nsSNPs was carried out with PSIC score (>0.5). A group of 4 nsSNPs, rs149531418 (G330E), rs121908251 (C102S), rs121908254 (C174R), and rs372499913 (G107D), were cumulatively considered as highly deleterious as these 4 nsSNPs were supported 100% by all of the state-of-the-art tools while only Mutation Assessor disagrees with the result of G107D by other tools. Even though the SNAP2 agreed with G330E, C102S, and C174R as effect, the score is <50 (Table 1S4). During the prediction matching analysis, the nsSNPs, rs149531418 (G330E), rs121908251 (C102S), rs121908254 (C174R), and rs372499913 (G107D), were agreed by the state-of-the-art tools, PolyPhen (>0.5), PANTHER (>450), SNPs&GO (>0.5), SIFT (=0), Mutation Taster (<0.5), CADD (>15), MetaLR (>0.5), M-CAP (>0.025), PANTHER (probably damaging time > 450my possibly damaging” (450my > time > 200my, “probably benign” (time < 200my)), VEST3 (>0.5), LRT (>0.001), PROVEAN (>−2.667), FATHMM-MKL (<0.5), PhD-SNP (>0.5), SNP-GO (>0.5), SNAP2 (−100 (fully neutral) and +100 (strong effect)), DANN (>0.5), Mutation Assessor (>0.65) (−5.545 to 5.975 (higher score‐>more damaging)), FATHMM (>0.453), and highly deleterious nsSNPs on CCBE1 gene. Analysis of 407 nsSNPs of CCBE1 gene for the prediction of pathogenic nsSNPs was almost similar (87%) for the SIFT and PolyPhen while disagreement was 36%. We selected for further study 23 nsSNPs which were predicated deleterious/damaging by both SIFT and PolyPhen. More than 100% of overlapped similarity was observed between the SIFT, M-CAP, CADD, PolyPhen, and FATHMM-MKL, on pathogenic nsSNPs. Similarity between SNP-GO and PhD-SNP is 13%, and disagreement is 73% while between SIFT and SNP-GO dissimilarity was 82%. Almost more than 50% of the predictions of pathogenic nsSNPs were found to be disagreed between SIFT, and PROVEAN, SNAP2, PANTHER, MetaLR, Mutation Assessor, FATHMM, VEST3, and MutPred. Moreover, similarities in between these tools (SNAP2, MetaLR, Mutation Taster, DANN, FATHMM, and LRT) for predication were more than 70%. Almost 60% agreement for pathogenic nsSNPs was present in predication tools (MutPred, VEST3, PhD-SNP, and Mutation Assessor). The results of all the predication algorithms were found statistically significant and were highly correlated. Student’s t-test between the tools was significant at value <0.001. The results are shown in Table 3 as well as the cumulative score and total significance of all the tools in the study are shown in Figure 1S4.



D: deleterious; T: tolerated; U: unknown; L: low; N: neutral; M: medium; P: polymorphism; E: effect. Thresholds for all these predication tools are given in the S4 fill.
3.4. Conservation Analysis

We analyzed the degree of conservations of CCBE1 residues by using the ConSurf web server. The results of the ConSurf analysis indicated that 23 deleterious missense SNPs are located in highly conserved regions (7-8-9). Among these 23 missenses variants, 13 were located in the highly conserved positions: 11 (C75S, P87S, P290L, A96G, G107D, R118L, G330E, D336N, R125W, Q353R, and T153N) were predicted as functional and exposed residues and the other 2 (C102S and C174R) were predicted as buried and structural residues. The S19N was predicted as conserved and buried residue, and the other 8 (T144M, R167W, P249S, R301W, G327R, K355T, D397Y, and D41E) were exposed residues. The results are shown in Figure 3.

3.5. Project Hope

All of the 23 nonsynonymous SNPs that were predicted to be deleterious and damaging by both SIFT and PolyPhen software were submitted to Project HOPE software. The findings revealed that rs149531418 resulted in the substitution of glycine (wild type) into glutamic acid (mutant) at position 330. The mutant residue is bigger than the wild-type residue. The wild-type residue charge was neutral, and the mutant residue charge was negative. The wild-type residue is more hydrophobic than the mutant residue as well as the mutation is located within a domain, annotated in UniProt as collagen-like 2, and the mutation introduces an amino acid with different properties, which can disturb this domain and abolish its function. Neither our mutant residue nor another residue type with similar properties was observed at this position in other homologous sequences. Based on conservation scores, this mutation is probably damaging to the protein. The mutant residue is located near a highly conserved position. The rs121908251 resulted in the substitution of cysteine (wild type) into serine (mutant type) at position 102. The wild-type residue is more hydrophobic than the mutant residue. The variant is annotated with severity: disease, and the mutation is located in a region with known splice variants, described as C- > S (in HKLLS1; dbSNP: rs121908251). The mutant and wild-type residues are not very similar. Based on this conservation information, this mutation is probably damaging to the protein. This mutant residue is located near a highly conserved position. The rs121908254 shows the substitution of cysteine (wild type) into arginine (mutant type) at position 174. The mutant residue is bigger than the wild-type residue. The wild-type residue charge was neutral, and the mutant residue charge was positive. The wild-type residue is more hydrophobic than the mutant residue. The mutation is located within a domain, annotated in UniProt as EGF-like, calcium-binding. The mutation introduces an amino acid with different properties, which can disturb this domain and abolish its function. The variant is annotated with severity: disease, and mutation is located in a region with known splice variants, described as C- > R (in HKLLS1; dbSNP: rs121908254). The mutant and wild-type residues are not very similar. Based on this conservation information, this mutation is probably damaging to the protein. The mutant residue is located near a highly conserved position. The rs372499913 indicates the substitution of glycine (wild type) into aspartic acid (mutant type) at position 107. The mutant residue is bigger than the wild-type residue. The wild-type residue charge was neutral, and the mutant residue charge was negative. The wild-type residue is more hydrophobic than the mutant residue. The mutant and wild-type residues are not very similar. Based on this conservation information, this mutation is probably damaging to the protein. Our mutant residue is located near a highly conserved position. SNP rs147208835 results in the substitution of arginine (wild type) into tryptophan (mutant type) at position 125. The mutant residue is bigger than the wild-type residue. The wild-type residue charge was positive, and the mutant residue charge was neutral. The mutant residue is more hydrophobic than the wild-type residue. The mutant residue was not among the other residue types observed at this position in other homologous proteins. However, residues that have some properties in common with your mutated residue were observed. This means that in some rare cases, your mutation might occur without damaging the protein. The mutant residue is located near a highly conserved position.

3.6. Association of SNPs with Highly Conserved Buried (Structural) and Exposed (Functional) Amino Acid Residues in CCBE1 Protein

CCBE1 from a structural point of view expresses as a 406 amino acid long protein having 11 exons located at 18q21.32. CCBE1 sequence-based structural-functional analysis was performed using Clustal Omega-based multiple sequence alignment analysis. For this analysis, the CCBE1 protein sequence (UniProt ID: Q6UXH8) was retrieved from the UniProt Knowledgebase. The CCBE1 protein sequence was blasted against the UniProtKB/SwissProt entries and aligned using Clustal Omega with default settings. The results generated by the Clustal Omega tool consist of CCBE1 protein sequence aligned with other phylogenetically close sequences from other organisms. The results contain a colorimetric conservation score in the range of 1–10. Multiple sequence alignment using Clustal Omega revealed that the human CCBE1 protein sequence contains a number of conserved residues and motifs. The highly conserved amino acid residues in human CCBE1 protein were G262, P264, G265, G270, P272, G273, G276, R284, G285, R315, G317, R322, G323, G329, A345, E368, F370, P371, P374, P381, E382, D385, and D391. There are twenty-four different conserved residues Figure 4.

3.7. Prediction of Pathogenic Amino Acid Substitutions by MutPred2

MutPred2 considers several molecular characteristics of amino acid residues to predict whether an amino acid substitution is disease-related or neutral in humans. The score it provides is the probability predicted for an amino acid substitution should affect the function of the respective protein or not. The threshold score for pathogenicity prediction is 0.5, and a MutPred2 score ≥0.8 can be considered as a highly confident one. All substitutions have prediction scores ≤0.5. Table 4 provides MutPred2 outcomes.

SNPsActionable/confident hypothesisProbability value

C174RGain of intrinsic disorder0.390.009
Loss of disulfide linkage at C1740.210.020

D336NAltered disorder interface0.290.02
Loss of loop0.260.05
Loss of proteolytic cleavage at D3360.110.05
Altered coiled coil0.110.04

G107DAltered transmembrane protein0.290.0003
Loss of loop0.270.02
Loss of disulfide linkage at C1020.260.004
Gain of proteolytic cleavage at R1080.150.01

C102SLoss of disulfide linkage at C1020.550.0003
Loss of helix0.280.03
Loss of pyrrolidone carboxylic acid at Q1000.190.002
Altered metal binding0.350.008
Altered transmembrane protein0.320.00007

G330ELoss of B factor0.270.02
Gain of loop0.04

G327RLoss of B factor0.270.02

P290LAltered disordered interface0.360.008
Loss of B factor0.290.01

Q353RAltered disordered interface0.290.03
Altered coiled coil0120.04

T153NLoss of strand0.260.04
Gain of disulfide linkage at C1500.230.01

C75SAltered metal binding0.400.006
Loss of disulfide linkage at C750.300.001
Loss of helix0.270.05

P87SGain of helix0.280.02
Gain of disulfide linkage at C850.200.02
Altered metal binding0.250.03
Loss of sulfation at Y900.090.003

R118LAltered disordered interface0.270.40
Loss of disulfide linkage at C1130.190.02
Gain of photolytic cleavage at D1200.160.009
Loss of sulfation at Y1140.020.02

P181SGain of phosphorylation at Y1800.370.007
Loss of acetylation at K1790.210.03
Gain of N-linked glycosylation at N1820.030.03

A96GAltered transmembrane protein0.300.0001
Loss of helix0.290.02
Gain of disulfide linkage at C980.250.006
Gain of pyrrolidone carboxylic at Q1000.200.002

P249SGain of loop0.310.004
Loss of B factor0.290.02
Gain of phosphorylation at Y2440.240.04
Gain of o-linked glycosylation at P2490.120.04

3.8. Prediction of Stability of the Mutated Protein due to SNPs by iStable 2.0

Web tool iStable 2.0 was used to analysis for protein stability prediction. This web tool consists of 11 sequence- and structure-based prediction tools, and a machine learning approach is used for all outputs. Mutations were run from sequence analysis due to the unavailability of experimental structure. The results showed that G330E, C174R, G327R, P290L, D41E, A96G, T114M, D397Y, S19N, and Q359RT have increased stability while P249S, R167W, R301W, C75S, P87S, R118L, T153N, D336N, R125W, K355T, G107D, and C102S showed decreased stability. Table 5 provides iStable 2.0 predictions.

AASConfidence scoreStability


3.9. Surface and Solvent Accessibility of Residues and CCBE1 Secondary Structure by NetSurfP-2.0

Surface accessibility (exposed or buried) of amino acids in a given protein was predicated by NetSurfP-2.0, which provides a relative and absolute accessible surface area of each residue. It also predicts the protein secondary structure. Relative surface accessibility: red upward elevation is exposed to residue, and sky blue downward elevation is buried residue; the threshold is at 25%. Secondary structure is as follows: orange spiral = helix, indigo arrow = strand, and pink straight line = coil. Disorder is represented as black swollen line; thickness of line equals the probability of disordered residue. Figure 5 shows NetSurfP-2.0 outcomes.

3.10. 3D Modelling of CCBE1 and Its Mutants

Phyre2 was used for 3D structure generation of wild‐type CCBE1 protein and 22 mutants. For generating mutant protein 3D structure, nsSNP substitutions were made individually in CCBE1 protein sequence and then submitted to Phyre2, which predicted their 3D structures. Phyre2 used c5to3B as a template for 3D model prediction because it was the highest similar template according to the Phyre2 server. TM‐scores and RMSD values were calculated for each of the mutant models. The TM‐score shows us the topological similarity while RMSD values show the average distance between α‐carbon backbones of wild and mutant models. Higher RMSD values predict greater mutant structure deviation from wild type. The model for the mutant R118L (rs115982879) showed the greatest deviation having 1.56B RMSD value followed by A96G (rs149792489), S19N (rs374941368), and C174R (rs121908254) with 1.50B, 1.44B, and 1.46B RMSD values, respectively. R125W, C75S, and T153N showed 0.89B, 0.90B, and 0.85B RMSD values, thus showing no variation in structure from wild type. Other nsSNPs showed slight variation which included G327R (1.36B RMSD), P290L (1.3.6B RMSD), Q353T (1.3.2B RMSD), P290L (1.25B RMSD), D336N (1.25B RMSD), C102R (1.22B RMSD), R167W (1.16B RMSD), P87L (1.14B RMSD), G107D (1.13B RMSD), T144M (1.13B RMSD), G330R (1.12B RMSD), D41E (1.12B RMSD), D297Y (1.06B RMSD), R301W (1.02B RMSD), and K355T (1.01B RMSD). TM‐scores and RMSD values are given in Table 6. Four nsSNPs (R118L, A96G, S19N, and C174R) having the highest RMSD values were selected and submitted to I‐TASSER for remodeling. Protein structure generated by the I‐TASSER is the most reliable as it is the most advanced modelling tool. Each of these 3 mutants was studied and superimposed using Chimera 1.11 over the wild‐type CCBE1 protein, shown in Figures 6(a)6(d).

SNP-IDResidual changeTM-scoreRMSD valuesSNP-IDResidual changeTM-scoreRMSD values


3.11. Predicted PTMs (Post‐Translation Modifications)

GPS‐MSP 3.0 was used for this purpose which predicted no sites in CCBE1 to be methylated. GPS 3.0 and NetPhos 3.1 predicted CCBE1 phosphorylation sites which are given in Table S1. 62 residues (Ser: 23, Thr: 22, and Tyr: 17) were predicted by NetPhos 3.1 to have phosphorylation potential. On the other hand, 18 residues (Ser: 12, Thr: 06, and Tyr: 00) were predicted by GPS 3.0 to be capable of getting phosphorylated. BDM‐PUB and UbPred were used for ubiquitylation prediction. BDM-PUB predicted 11 lysine residues to get ubiquitinated, while UbPred predicted none of the lysine residues to get ubiquitinated. Among those predicted by BDM‐PUB, none was located at a highly conserved or deleterious nsSNP region. The results obtained are labeled in Table S1. NetOGlyc4.0 was used for the prediction of potential glycosylation sites. The output showed all the possible sites for glycosylation in which positions 19, 144, and 153 were predicted to be glycosylated with scores of 0.34, 0.43, and 0.17 in wild‐type CCBE1 protein. Interestingly, mutant S19N showed loss of glycosylation site at position 19 while T144M also showed loss of glycosylation sites at position 144. All the scores for the wild‐type and mutant proteins are given in Table S2.

3.12. Ligand-Binding Site Prediction by FTSite

Sites for ligand-binding were predicted by FTSite algorithms and visualized and further analyzed using PyMOL. By this tool, 3 ligand-binding sites were identified in human CCBE1 protein (Figures 7(a) and 7(b)). Site 1 consisted of 14 residues; site 2 and site 3 consisted of 7 and 5 residues. Some of the substitutions in twenty-two substituted positions predicted by the SIFT server lie in the predicted ligand-binding sites (T153N and R167W) (Table S3).

4. Discussion

Several studies have linked the CCBE1 gene to single-nucleotide polymorphisms in the cases of lymph vessel dysplasia [13, 14]. Utilizing state-of-the-art in silico methods, the current research explored the impact of SNPs on the structural and interactive behaviors of the CCBE1 protein. The most pathogenic polymorphisms in different genes have been screened using these methods in a sequential order [42, 56]. The current study also used the sequential application of all these methods to classify deleterious variants in CCBE1 that may interact with the machinery’s role in extracellular matrix remodeling and migration by silencing its function. We screened 73845 SNPs in the CCBE1 gene through multiple dbSNP databases for their effect on the gene’s structure and interactions with a variety of protein molecules. Various in silico methods were used to screen the pathogenicity of 407 retrieved nonsynonymous SNPs. Our study found 23 nsSNPs that were predicted to be deleterious by SIFT and PolyPhen2 but instead verified through other tools (PROVEAN, FATHMM, LRT, M-CAP, VEST3, CAAD, MetaLR, Mutation Assessor, Mutation Taster, and FATHMM-MKL, SNP-GO, PhD-SNP, PANTHER, SNAP2, and MutPred). Four nsSNPs were classified as highly pathogenic which were rs149531418, rs121908251, rs121908254, and rs372499913. This is a lower number than which was previously estimated using the same methods in different genes [56, 57]. The two of the variant shown in our study (C102S, C174R) are already reported for Hennekam syndrome in a study [11], while the other two variants (G330E and G107D) are not reported until now for Hennekam syndrome. Highly pathogenic variants were selected on the basis of the impact of nsSNPs on sequence conservation, sequence attributes, and structural impute [58]. The chosen state-of-the-art tools covered the largest possible range of methods (AS: alignment score; NN: neural networks; HMM: hidden Markov models; SVM: support vector machine; BC: Bayesian classification) for predicting pathogenic nsSNPs [58]. Since essential amino acids that are involved in a wide range of biological methods and processes, particularly protein interactions, are highly modified and conserved, SNPs on conserved loci are more likely to cause damage than SNPs on nonconserved loci [59]. In total 23 nsSNPs, only 11 SNPs are located at evolutionary conserved, exposed, and functionally important residues which are C75S, P87S, P290L, A96G, G107D, R118L, G330E, D336N, R125W, Q353R, and T153N. There were 2 nsSNPs (C102S and C174R) located at conserved, buried, and structurally important residues. All the rest of the nsSNPs were found to be located in either only exposed or buried residues which were not predicted to have any structural or functional importance in CCBE1 protein. These 11 nsSNPs for CCBE1 have not yet reported with patients in Hennekam disorder, and in future, these can be considered pathogenic nsSNPs when reported in Hennekam patients. For prediction of protein stability, I‐STAB2 web server was used which predicted nsSNP rs149531418, rs121908254, rs147681552, rs192224843, rs147974432, rs141125426, rs374941368, and rs149792489 increased stability while C75S, P87S, R125W, K355T, D336N, T153N, P87S, R118L, R301W, P249S, and R167W decrease protein stability. These nsSNPs can be used as marker for diagnostic and revealing new therapeutic targets for Hennekam disorder. RAMPAGE values were used to verify all of the modeled structures. Protein structures with RAMPAGE values greater than 80% as core values are thought to be higher [60]. For the structure given in Figure 5(a) (CCEB1 wild‐type), RAMPAGE values were 75.5% favored residues, 19.1% allowed, 4.5% generally allowed, and disallowed 0.9%. Similarly, for mutants R118L (80.0% favored residues, 13.6% allowed, 4.5% generally allowed, and disallowed 1.8%), A96G (76.4% favored residues, 16.4% allowed, 5.5% generally allowed, and disallowed 1.8%), C174R (79.1% favored residues, 15.5% allowed, 2.7% generally allowed, and disallowed 0.9%), and S19N (78.2% favored residues, 16.4% allowed, 4.5% generally allowed, and disallowed 0.9%), all the structures were somehow validated. PTMs have been shown to be important in cell signaling and protein-protein interactions, as well as other significant events such as biological processes, control protein structures, and functions [61, 62]. In this analysis, we looked to see if the chosen nsSNPs modified the PTMs of the CCBE1 protein. A variety of bioinformatics methods were used to predict PTM sites in our understudied protein. Methylation is a critical PTM because lysine residues in some proteins are methylated, which influences their binding to DNA and changes gene expression. Another important mechanism for protein regulation acts as a molecular switch of protein to adapt it for functions such as protein structure conformational changes, protein activation and deactivation, and signal transduction pathways [6366]. S19 is highly conserved, exposed, and functionally significant, according to the ConSurf conservation profile, indicating its significance. Phosphorylation potential is seen at position S19, which also contains one of the most damaging nsSNPs (rs137 6162684), which really is structurally important and highly conserved (ConSurf prediction), making it highly important. Ubiquitylation is a protein degradation mechanism that also helps in DNA damage repair [67]. It is crucial to the function and stability of proteins. It plays a structural role in protein-protein interactions. Phosphorylation is the only PTM that can have a major impact on CCBE1 protein structure and function, as shown by these PTM predictions, with residuals S19 and T153 being the most significant phosphorylation sites. STRING and GeneMANIA predictions show that ADAMTS3 is the most interactive gene with CCBE1, supported by VEGFC and FLT4. CCBE1 ADAMTS3, VEGFC, FLTR4, and GJC2 are thought to be related with either Hennekam disorder or its related symptoms in many diseases, including rheumatoid arthritis [8, 13, 68, 69]. As a result of their interaction patterns and coexpression profiles, it can be inferred that some of the most harmful nsSNPs in the CCBE1 gene will influence and possibly disrupt the normal functioning of other interacting genes. This demonstrates the significance of these interacting and coexpressing genes, which may be significant during the Hennekam syndrome or other primary immunodeficiency disorders. FTSite was used to look into the impact of substitutions on protein function. The FTSite server predicted three ligand-binding sites, each with 14, 7, and 9 residues. We discovered that R167W and T153N substitutions are involved in the ligand-binding site and form the catalytic coordination sphere, which can affect the CCBE1 protein’s binding affinity. Since our research was thorough, it contains all of the necessary data and analysis for identifying the most harmful nsSNPs. Any research, including ours, has some limitations. The focus of our research is on mathematical and computational algorithms used in programming tools and web servers. As a consequence, experimental research is needed to confirm these findings. Our findings shed light on the CCBE1 gene’s nsSNPs, protein 3D structure, PTM potential sites, and gene-gene interaction, and all of which may help researchers better understand the gene’s role in autoimmunity and related diseases in the future.

5. Conclusion

The impact of nsSNPs on the functional and structural deviations in the CCBE1 protein was predicted using a variety of various state-of-the-art tools. On the CCBE1 protein, structural homology-based methods and sequence homology-based techniques have identified four nsSNPs as potentially damaging: rs149531418 (G330E), rs121908251 (C102S), rs121908254 (C174R), and rs372499913 (G107D). The pathogenicity of nsSNPs can be predicted in a stepwise and accurate manner (SIFT > PolyPhen > CADD > FATHMM-MKK > M-CAP > PANTHER > Mutation Taster > LRT > DANN > MetaLR > SNAP2 > VEST3> MutPred > PhD-SNP > Mutation Assessor > PROVEAN > SNP-GO > Cumulative), prediction matching among the tools. As a consequence, the findings of these tools for other studies may be considered more reliable. The importance of rs374941368 and rs200149541 in the prediction of post-transcriptional modifications was highlighted because it affects a possible phosphorylation location. In the future, the 4 reported extremely deleterious, protein stability decreasing, and nsSNPs in highly conserved positions could be used as Hennekam syndrome marker nsSNPs. Even though we performed a thorough in silico study, further research is needed to fully understand the impact of these nsSNPs on protein structure and function.

Data Availability

The data used in the article are given with the information from where the data were taken, e.g., (

Ethical Approval

The study did not include any living objects to be studied; therefore, no ethical approval was needed.

Conflicts of Interest

The authors declare that they have no conflicts of interest.


The work was carried out within the framework of state research at the Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences, project number AAAA-A21-121012090091-6.

Supplementary Materials

Supplementary File 1. Table 1: prediction of phosphorylation sites by NetPhos 3.1 and GPS 3.0. Table 2: CCBE1 ubiquitination prediction results by BDM-PUB. Supplementary File 2. Table 1: NetOGlyc 4.0 results for CCBE1 (wild type and final selected mutants). Supplementary File 3. Table 1: residue at ligand-binding sites of CCBE1 protein. Supplementary File 4. Figure 1: overall significance of the predication tools used in the study (shows the significance of the different predication tools used in the study). Table 1: confirmation of the deleterious nsSNPs by other prediction software (shows the results of the other than SIFT and PolyPhen2 predication tools). (Supplementary Materials)


  1. T. Karpanen and K. Alitalo, “Molecular biology and pathology of lymphangiogenesis,” Annual Review of Pathology: Mechanisms of Disease, vol. 3, no. 1, pp. 367–397, 2008. View at: Publisher Site | Google Scholar
  2. G. Oliver and K. Alitalo, “The lymphatic vasculature: recent progress and paradigms,” Annual Review of Cell and Developmental Biology, vol. 21, no. 1, pp. 457–483, 2005. View at: Publisher Site | Google Scholar
  3. L. N. Cueni and M. Detmar, “New insights into the molecular control of the lymphatic vascular system and its role in disease,” Journal of Investigative Dermatology, vol. 126, no. 10, pp. 2167–2177, 2006. View at: Publisher Site | Google Scholar
  4. R. I. Hilliard, J. B. McKendry, and M. J. Phillips, “Congenital abnormalities of the lymphatic system: a new clinical classification,” Pediatrics, vol. 86, no. 6, pp. 988–994, 1990. View at: Google Scholar
  5. R. C. M. Hennekam, R. A. Geerdink, B. C. J. Hamel et al., “Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation,” American Journal of Medical Genetics, vol. 34, no. 4, pp. 593–600, 1989. View at: Publisher Site | Google Scholar
  6. M. Alders, A. Mendola, L. Adès et al., “Evaluation of clinical manifestations in patients with severe lymphedema with and without CCBE1 mutations,” Molecular Syndromology, vol. 4, no. 3, pp. 107–113, 2013. View at: Publisher Site | Google Scholar
  7. M. Alders, L. Al-Gazali, I. Cordeiro et al., “Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome,” Human Genetics, vol. 133, no. 9, pp. 1161–1167, 2014. View at: Publisher Site | Google Scholar
  8. P. Brouillard, L. Dupont, R. Helaers et al., “Loss of ADAMTS3 activity causes Hennekam lymphangiectasia-lymphedema syndrome 3,” Human Molecular Genetics, vol. 26, no. 21, pp. 4095–4104, 2017. View at: Publisher Site | Google Scholar
  9. B. M. Hogan, F. L. Bos, J. Bussmann et al., “CCBE1 is required for embryonic lymphangiogenesis and venous sprouting,” Nature Genetics, vol. 41, no. 4, pp. 396–398, 2009. View at: Publisher Site | Google Scholar
  10. F. L. Bos, M. Caunt, J. Peterson-Maduro et al., “CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo,” Circulation Research, vol. 109, no. 5, pp. 486–491, 2011. View at: Publisher Site | Google Scholar
  11. M. Alders, B. M. Hogan, E. Gjini et al., “Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans,” Nature Genetics, vol. 41, no. 12, pp. 1272–1274, 2009. View at: Publisher Site | Google Scholar
  12. M. Jeltsch, S. K. Jha, D. Tvorogov et al., “CCBE1Enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation,” Circulation, vol. 129, no. 19, pp. 1962–1971, 2014. View at: Publisher Site | Google Scholar
  13. S. Shah, L. K. Conlin, L. Gomez et al., “CCBE1 mutation in two siblings, one manifesting lymphedema-cholestasis syndrome, and the other, fetal hydrops,” PLoS One, vol. 8, no. 9, Article ID e75770, 2013. View at: Publisher Site | Google Scholar
  14. F. Connell, K. Kalidas, K. Kalidas et al., “Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia,” Human Genetics, vol. 127, no. 2, pp. 231–241, 2010. View at: Publisher Site | Google Scholar
  15. C. C. Jackson, L. Best, L. Lorenzo et al., “A multiplex kindred with hennekam syndrome due to homozygosity for a CCBE1 mutation that does not prevent protein expression,” Journal of Clinical Immunology, vol. 36, no. 1, pp. 19–27, 2016. View at: Publisher Site | Google Scholar
  16. T. Can, “Introduction to bioinformatics,” in miRNomics: MicroRNA Biology and Computational Analysis, M. Yousef and J. Allmer, Eds., pp. 51–71, Humana Press, Totowa, NJ, USA, 2014. View at: Google Scholar
  17. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ),” Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995. View at: Publisher Site | Google Scholar
  18. M. W. Nachman, “Single nucleotide polymorphisms and recombination rate in humans,” Trends in Genetics, vol. 17, no. 9, pp. 481–485, 2001. View at: Publisher Site | Google Scholar
  19. J. E. Lee, J. H. Choi, J. H. Lee, and M. G. Lee, “Gene SNPs and mutations in clinical genetic testing: haplotype-based testing and analysis,” Mutation Research, vol. 573, no. 1-2, pp. 195–204, 2005. View at: Publisher Site | Google Scholar
  20. R. Rajasekaran, C. Georgepriyadoss, C. Sudandiradoss, K. Ramanathan, P. Rituraj, and S. Rao, “Computational and structural investigation of deleterious functional SNPs in breast cancer BRCA2 gene,” Chinese Journal of Biotechnology, vol. 24, no. 5, pp. 851–856, 2008. View at: Publisher Site | Google Scholar
  21. N. Kamatani, A. Sekine, T. Kitamoto et al., “Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP Maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs,” The American Journal of Human Genetics, vol. 75, no. 2, pp. 190–203, 2004. View at: Publisher Site | Google Scholar
  22. M. Krawczak, E. V. Ball, I. Fenton et al., “Human Gene Mutation Database?A biomedical information and research resource,” Human Mutation, vol. 15, no. 1, pp. 45–51, 2000. View at: Publisher Site | Google Scholar
  23. L. Prokunina and M. E. Alarcón-Riquelme, “Regulatory SNPs in complex diseases: their identification and functional validation,” Expert Reviews in Molecular Medicine, vol. 6, no. 10, pp. 1–15, 2004. View at: Publisher Site | Google Scholar
  24. P. D. Stenson, M. Mort, E. V. Ball et al., “The human gene mutation database: 2008 update,” Genome Medicine, vol. 1, no. 1, p. 13, 2009. View at: Publisher Site | Google Scholar
  25. Z. Ning, A. J. Cox, and J. C. Mullikin, “SSAHA: a fast search method for large DNA databases,” Genome Research, vol. 11, no. 10, pp. 1725–1729, 2001. View at: Publisher Site | Google Scholar
  26. D. Stojanov, S. Koceski, A. Mileva, N. Koceska, and C. M. Bande, “Towards computational improvement of DNA database indexing and short DNA query searching,” Biotechnology & Biotechnological Equipment, vol. 28, no. 5, pp. 958–967, 2014. View at: Publisher Site | Google Scholar
  27. M. Bhagwat, “Searching NCBI’s dbSNP database,” Current Protocols in Bioinformatics, 2010. View at: Publisher Site | Google Scholar
  28. D. Warde-Farley, S. L. Donaldson, O. Comes et al., “The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function,” Nucleic Acids Research, vol. 38, no. 2, pp. W214–W220, 2010. View at: Publisher Site | Google Scholar
  29. P. C. Ng and S. Henikoff, “Predicting the effects of amino acid substitutions on protein function,” Annual Review of Genomics and Human Genetics, vol. 7, no. 1, pp. 61–80, 2006. View at: Publisher Site | Google Scholar
  30. P. Kumar, S. Henikoff, and P. C. Ng, “Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm,” Nature Protocols, vol. 4, no. 7, pp. 1073–1081, 2009. View at: Publisher Site | Google Scholar
  31. I. A. Adzhubei, S. Schmidt, L. Peshkin et al., “A method and server for predicting damaging missense mutations,” Nature Methods, vol. 7, no. 4, pp. 248-249, 2010. View at: Publisher Site | Google Scholar
  32. Y. Choi, G. E. Sims, S. Murphy, J. R. Miller, and A. P. Chan, “Predicting the functional effect of amino acid substitutions and indels,” PLoS One, vol. 7, no. 10, Article ID e46688, 2012. View at: Publisher Site | Google Scholar
  33. J. Li, L. Shi, K. Zhang et al., “VarCards: an integrated genetic and clinical database for coding variants in the human genome,” Nucleic Acids Research, vol. 46, no. D1, pp. D1039–D1048, 2018. View at: Publisher Site | Google Scholar
  34. R. Calabrese, E. Capriotti, P. Fariselli, P. L. Martelli, and R. Casadio, “Functional annotations improve the predictive score of human disease-related mutations in proteins,” Human Mutation, vol. 30, no. 8, pp. 1237–1244, 2009. View at: Publisher Site | Google Scholar
  35. H. Tang and P. D. Thomas, “PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation,” Bioinformatics, vol. 32, no. 14, pp. 2230–2232, 2016. View at: Publisher Site | Google Scholar
  36. M. Hecht, Y. Bromberg, and B. Rost, “Better prediction of functional effects for sequence variants,” BMC Genomics, vol. 16, no. 8, p. S1, 2015. View at: Publisher Site | Google Scholar
  37. B. Li, V. G. Krishnan, M. E. Mort et al., “Automated inference of molecular mechanisms of disease from amino acid substitutions,” Bioinformatics, vol. 25, no. 21, pp. 2744–2750, 2009. View at: Publisher Site | Google Scholar
  38. C.-W. Chen, M.-H. Lin, C.-C. Liao, H.-P. Chang, and Y.-W. Chu, “iStable 2.0: predicting protein thermal stability changes by integrating various characteristic modules,” Computational and Structural Biotechnology Journal, vol. 18, pp. 622–630, 2020. View at: Publisher Site | Google Scholar
  39. F. Sievers, A. Wilm, D. Dineen et al., “Fast, scalable generation of high‐quality protein multiple sequence alignments using Clustal Omega,” Molecular Systems Biology, vol. 7, no. 1, p. 539, 2011. View at: Publisher Site | Google Scholar
  40. A. M. Waterhouse, J. B. Procter, D. M. A. Martin, M. Clamp, and G. J. Barton, “Jalview Version 2--a multiple sequence alignment editor and analysis workbench,” Bioinformatics, vol. 25, no. 9, pp. 1189–1191, 2009. View at: Publisher Site | Google Scholar
  41. C. Berezin, F. Glaser, J. Rosenberg et al., “ConSeq: the identification of functionally and structurally important residues in protein sequences,” Bioinformatics, vol. 20, no. 8, pp. 1322–1324, 2004. View at: Publisher Site | Google Scholar
  42. H. Venselaar, T. A. Te Beek, R. K. Kuipers, M. L. Hekkelman, and G. Vriend, “Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces,” BMC Bioinformatics, vol. 11, no. 1, p. 548, 2010. View at: Publisher Site | Google Scholar
  43. M. S. Klausen, M. C. Jespersen, H. Nielsen et al., “NetSurfP‐2.0: improved prediction of protein structural features by integrated deep learning,” Proteins: Structure, Function, and Bioinformatics, vol. 87, no. 6, pp. 520–527, 2019. View at: Publisher Site | Google Scholar
  44. L. A. Kelley, S. Mezulis, C. M. Yates, M. N. Wass, and M. J. E. Sternberg, “The Phyre2 web portal for protein modeling, prediction and analysis,” Nature Protocols, vol. 10, no. 6, pp. 845–858, 2015. View at: Publisher Site | Google Scholar
  45. O. Carugo and S. Pongor, “A normalized root-mean-square distance for comparing protein three-dimensional structures,” Protein Science: A Publication of the Protein Society, vol. 10, no. 7, pp. 1470–1473, 2001. View at: Publisher Site | Google Scholar
  46. Y. Zhang and J. Skolnick, “TM-align: a protein structure alignment algorithm based on the TM-score,” Nucleic Acids Research, vol. 33, no. 7, pp. 2302–2309, 2005. View at: Publisher Site | Google Scholar
  47. Y. Zhang, “I-TASSER server for protein 3D structure prediction,” BMC Bioinformatics, vol. 9, no. 1, p. 40, 2008. View at: Publisher Site | Google Scholar
  48. A. Roy, A. Kucukural, and Y. Zhang, “I-TASSER: a unified platform for automated protein structure and function prediction,” Nature Protocols, vol. 5, no. 4, pp. 725–738, 2010. View at: Publisher Site | Google Scholar
  49. J. Yang, R. Yan, A. Roy, D. Xu, J. Poisson, and Y. Zhang, “The I-TASSER Suite: protein structure and function prediction,” Nature Methods, vol. 12, no. 1, pp. 7-8, 2015. View at: Publisher Site | Google Scholar
  50. E. F. Pettersen, T. D. Goddard, C. C. Huang et al., “UCSF Chimera?A visualization system for exploratory research and analysis,” Journal of Computational Chemistry, vol. 25, no. 13, pp. 1605–1612, 2004. View at: Publisher Site | Google Scholar
  51. W. Deng, Y. Wang, L. Ma, Y. Zhang, S. Ullah, and Y. Xue, “Computational prediction of methylation types of covalently modified lysine and arginine residues in proteins,” Briefings in Bioinformatics, vol. 18, no. 4, pp. 647–658, 2017. View at: Publisher Site | Google Scholar
  52. Y. Xue, J. Ren, X. Gao, C. Jin, L. Wen, and X. Yao, “GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy,” Molecular & Cellular Proteomics, vol. 7, no. 9, pp. 1598–1608, 2008. View at: Publisher Site | Google Scholar
  53. N. Blom, S. Gammeltoft, and S. Brunak, “Sequence and structure-based prediction of eukaryotic protein phosphorylation sites,” Journal of Molecular Biology, vol. 294, no. 5, pp. 1351–1362, 1999. View at: Publisher Site | Google Scholar
  54. P. Radivojac, V. Vacic, C. Haynes et al., “Identification, analysis, and prediction of protein ubiquitination sites,” Proteins: Structure, Function, and Bioinformatics, vol. 78, no. 2, pp. 365–380, 2010. View at: Publisher Site | Google Scholar
  55. C. Steentoft, S. Y. Vakhrushev, H. J. Joshi et al., “Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology,” The EMBO Journal, vol. 32, no. 10, pp. 1478–1488, 2013. View at: Publisher Site | Google Scholar
  56. S. AbdulAzeez and J. F. Borgio, “In-silico computing of the most deleterious nsSNPs in HBA1 gene,” PLoS One, vol. 11, no. 1, Article ID e0147702, 2016. View at: Publisher Site | Google Scholar
  57. S. Abdulazeez, S. Sultana, N. B. Almandil, D. Almohazey, B. J. Bency, and J. F. Borgio, “The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching,” PLoS One, vol. 14, no. 2, Article ID e0212492, 2019. View at: Publisher Site | Google Scholar
  58. K. Khafizov, M. V. Ivanov, O. V. Glazova, and S. P. Kovalenko, “Computational approaches to study the effects of small genomic variations,” Journal of Molecular Modeling, vol. 21, no. 10, p. 251, 2015. View at: Publisher Site | Google Scholar
  59. M. P. Miller and S. Kumar, “Understanding human disease mutations through the use of interspecific genetic variation,” Human Molecular Genetics, vol. 10, no. 21, pp. 2319–2328, 2001. View at: Publisher Site | Google Scholar
  60. A. L. Morris, M. W. MacArthur, E. G. Hutchinson, and J. M. Thornton, “Stereochemical quality of protein structure coordinates,” Proteins: Structure, Function, and Genetics, vol. 12, no. 4, pp. 345–364, 1992. View at: Publisher Site | Google Scholar
  61. C. Dai and W. Gu, “p53 post-translational modification: deregulated in tumorigenesis,” Trends in Molecular Medicine, vol. 16, no. 11, pp. 528–536, 2010. View at: Publisher Site | Google Scholar
  62. Y. Shiloh and Y. Ziv, “The ATM protein kinase: regulating the cellular response to genotoxic stress, and more,” Nature Reviews Molecular Cell Biology, vol. 14, no. 4, pp. 197–210, 2013. View at: Publisher Site | Google Scholar
  63. J. Deutscher and M. H. Saier Jr., “Ser/Thr/Tyr protein phosphorylation in bacteria-for long time neglected, now well established,” Journal of Molecular Microbiology and Biotechnology, vol. 9, no. 3-4, pp. 125–131, 2005. View at: Publisher Site | Google Scholar
  64. J. Puttick, E. N. Baker, and L. T. J. Delbaere, “Histidine phosphorylation in biological systems,” Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, vol. 1784, no. 1, pp. 100–105, 2008. View at: Publisher Site | Google Scholar
  65. J. Cieśla, T. Frączyk, and W. Rode, “Phosphorylation of basic amino acid residues in proteins: important but easily missed,” Acta Biochimica Polonica, vol. 58, no. 2, pp. 137–148, 2011. View at: Google Scholar
  66. A. Sawicka and C. Seiser, “Sensing core histone phosphorylation-a matter of perfect timing,” Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, vol. 1839, no. 8, pp. 711–718, 2014. View at: Publisher Site | Google Scholar
  67. L. H. Gallo, J. Ko, and D. J. Donoghue, “The importance of regulatory ubiquitination in cancer and metastasis,” Cell Cycle, vol. 16, no. 7, pp. 634–648, 2017. View at: Publisher Site | Google Scholar
  68. A. Mendola, M. J. Schlögel, A. Ghalamkarpour et al., “Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema,” Molecular Syndromology, vol. 4, no. 6, pp. 257–266, 2013. View at: Publisher Site | Google Scholar
  69. B. Newman, F. Lose, M.-A. Kedda et al., “Possible genetic predisposition to lymphedema after breast cancer,” Lymphatic Research and Biology, vol. 10, no. 1, pp. 2–13, 2012. View at: Publisher Site | Google Scholar

Copyright © 2021 Khyber Shinwari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.